8hon MSN
Devendra Barlewar, a 47-year-old scientist, successfully received a rare third kidney transplant at Amrita Hospital, leaving him with five kidneys, on ...
Lack of steady income can cause patients to face difficulties in bearing treatment costs that can reach up to RM40,000 a year ...
22h
GlobalData on MSNFibroGen sells China unit to AstraZeneca for $160mAstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
A new 5 million dollar dialysis and nephrology unit at St. Peter's Medical Center is making dialysis blood transfusion and transplant treatments more comfortable for patients.
2h
Dealbreaker on MSNAstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M DealBy selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...
Devendra Barlewar, a scientist from the Union Ministry of Defence, successfully underwent his third kidney transplant.
A rare surgery in Delhi is making headlines, highlighting remarkable willpower and a groundbreaking medical achievement.
AstraZeneca will obtain the full rights to Roxadustat in China, FibroGen said, adding that it will retain the US and other ...
2h
Verywell Health on MSNDoes Creatine Cause Bloating?The short answer: water retention from creatine can cause bloating in some. Learn about GI symptoms and side effects from creatine supplements.
Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).
SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results